Target Audience (click to view)
This activity is designed to meet the needs of physicians and nurses.
Learning Objectives(click to view)
Upon completion of the educational activity, participants should be able to:
- Discuss the key findings of six studies presented at the 2016 annual scientific meeting of the American College of Allergy, Asthma & Immunology.
Method of Participation(click to view)
Release Date: 02/28/2017
Expiration Date: 02/28/2018
Statements of credit will be awarded based on the participant reviewing monograph, correctly answer 2 out of 3 questions on the post test, completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form at https://lms.physiciansweekly.com/course/view.php?id=38. You must participate in the entire activity to receive credit. If you have questions about this CME/CE activity, please contact AKH Inc. at email@example.com.
Credit Available(click to view)
CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly’s. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 0.5 contact hours.
Commercial Support(click to view)
There is no commercial support for this activity.
Disclosures(click to view)
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use & Investigational Product(click to view)
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer(click to view)
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
Faculty & Credentials(click to view)
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
Dorothy Caputo, MA, BSN, RN- CE Director of Accreditation
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH planners and reviewers have no relevant financial relationships to disclose.
Complete the Post Test(click to view)
New research was presented at ACAAI 2016, the annual scientific meeting of the American College of Allergy, Asthma & Immunology, from November 10 to 14 in San Francisco. The features below highlight some of the studies presented at the conference.
Smoking Among Asthmatic Teens
Previous research has shown that smoking rates among teens with asthma are relatively high. However, data are lacking on how smoking and smoking dependence differ between teens with asthma and those without the condition. For a study, researchers surveyed adolescents aged 13 to 19 about their smoking habits. When compared with participants who did not have asthma, teens with asthma were more likely to smoke, have some degree of nicotine dependence, and have tobacco dependence. Curiosity about cigarette smoking was identified as the primary reason why teens with asthma started smoking.
Asthma Risk & Access to Fresh Foods
Recent studies have linked obesity with a higher incidence of asthma and worse outcomes. A lack of access to healthy foods has been established as a driver of obesity, but few studies have assessed the impact of this phenomenon on asthma. Study investigators compared the prevalence of pediatric asthma between children with and without access to fruits, vegetables, and other fresh foods for a study. Among children without access, 21% had asthma, compared with a rate of 17% observed among those with access. Children in the study who lived more than 1 mile from a grocery store had 53% greater odds of having asthma.
The Effect of Introducing Allergenic Foods Early
Evidence suggests that the timing of introducing allergenic foods into an infant’s diet may influence their risk of developing allergic or autoimmune diseases. However, this research has yet to be comprehensively synthesized. To close this gap, investigators analyzed data from 146 studies evaluating the timing of allergenic food introduction during the first year of life for a meta-analysis. Peanut introduction at 4 to 11 months of age was associated with a lower risk for peanut allergy in two trials. Egg introduction at 4 to 6 months of age was associated with reduced risks for egg allergies in five trials. Gluten introduction was not associated with celiac disease risk.
Reducing Wide-Spectrum Antibiotic Use
Although the latest clinical guidelines recommend allergy testing to improve antimicrobial stewardship, data indicate that few hospitals have allergist-directed protocols dedicated to performing this task. For a study, patients who reported being allergic to penicillin upon hospital admission were screened to determine if they truly had the allergy. Among those who were tested, 88.5% were found to not have an allergy to penicillin. When clinicians received the results of these negative tests, they were able to reduce use of various wide-spectrum antibiotics by 34% to 68%. The researchers estimated that doing so prevented 504 inpatient days and 648 outpatient days among the 252 participants.
Perennial Vs Pre-Seasonal AIT
The long-term efficacy of perennial allergen immunotherapy (AIT) versus that of pre-seasonal AIT for grass pollen-induced allergic rhinitis has not been well established. A study was conducted in which researchers compared outcomes of patients with allergic rhinitis who were treated with pre-seasonal subcutaneous immunotherapy with those who underwent perennial treatment. Both groups experienced significant reductions in symptom medication scores upon completing AIT and at 15 years later, but the prolonged effects of treatment were more pronounced for those in the perennial treatment group. Patients in the perennial treatment group also experienced significantly fewer new sensitizations and were less likely to develop new-onset asthma 15 years after finishing AIT.
Improving Skin Prick Testing Proficiency
Data indicate that results of skin testing can vary depending on the method used, operator technique, and choice of skin. Proficiency testing of all healthcare providers who perform skin prick or puncture testing may minimize variability in technique and results for individual operators and among multiple operators. For a study, researchers evaluated an algorithm for determining skin testing proficiency using a single-head device. Participants were trained on the recommended application technique and then tested for proficiency using five applications each of positive histamine and negative glycero-saline controls per test set. Acceptable test set results ranged from 87% using calipers to 94% using rulers, with the majority of operators demonstrating proficiency. The specificity of testing with negative controls was 99%.
NEWS FROM ACAAI 2016
MORE FROM ACAAI 2016